Evidence map›Paper›PMID 31522968›Full record

ReviewJournal of infection and public health2020

Improved capacity for influenza surveillance in the WHO Eastern Mediterranean Region: Progress in a challenging setting.

Mamunur R Malik, Abdinasir Abubakar, Amgad E Kholy, Evans Buliva, Wasiq M Khan, Jaya Lamichhane, Ann Moen, Margaret McCarron, Kinda Zureick, Majdouline Obtel

Abstract readReview
In one paragraph

Review in Journal of infection and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Global respiratory virus surveillance: strengths, gaps, and way forward.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mamunur R MalikInfectious Hazard Management, Department of Health Emergency, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt. Electronic address: malikm@who.int.
Abdinasir AbubakarInfectious Hazard Management, Department of Health Emergency, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Amgad E KholyInfectious Hazard Management, Department of Health Emergency, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Evans BulivaInfectious Hazard Management, Department of Health Emergency, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Wasiq M KhanInfectious Hazard Management, Department of Health Emergency, World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.
Jaya LamichhaneDepartment of Infectious Hazard Management, WHO Health Emergency Programme, World Health Organization, Geneva, Switzerland.
Ann MoenDepartment of Infectious Hazard Management, WHO Health Emergency Programme, World Health Organization, Geneva, Switzerland.
Margaret McCarronInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kinda ZureickInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Majdouline ObtelLaboratory of Public Health, Preventive Medicine and Hygiene, Laboratory of Epidemiology, Clinical Research and Biostatistics, Department of Public Health, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe World Health Organization Regional Office for Eastern Mediterranean has partnered with the United States Centers for Disease Control and Prevention (CDC) to strengthen pandemic influenza preparedness and response in the Region since 2006. This partnership focuses on pandemic preparedness planning, establishing and enhancing influenza surveillance systems, improving laboratory capacity for detection of influenza viruses, estimating the influenza disease burden, and providing evidence to support policies for the introduction and increased use of seasonal influenza vaccines.

methodsVarious published and unpublished data from public and WHO sources, programme indicators of the CDC cooperative agreement and Pandemic Influenza Preparedness Framework were reviewed and analysed. Analyses and review of the programme indicators and published articles enabled us to generate information that was unavailable from only WHO sources.

resultsMost (19/22) countries of the Region have established influenza surveillance system; 16 countries in the Region have designated National Influenza Centres. The Region has seen considerable improvement in geographic coverage of influenza surveillance and influenza detection. Virus sharing has improved and almost all of the participating laboratories have achieved a 100% efficiency score in the WHO external quality assessment programme. At least seven countries have estimated their influenza disease burden using surveillance data and at least 17 are now using seasonal influenza vaccines as a control strategy for influenza illness.

conclusionThe Region has achieved substantial progress in surveillance and response to seasonal influenza, despite the adverse effects to the health systems of many countries due to acute and protracted emergencies and other significant challenges.

Indexed as

Centers for Disease Control and Prevention, U.S.Communicable Disease ControlHealth PolicyHumansInfluenza, HumanInfluenza VaccinesLaboratoriesMediterranean RegionMiddle EastPandemicsPublic Health SurveillanceRespiratory Tract InfectionsUnited StatesWorld Health OrganizationInfluenza VaccinesEastern Mediterranean RegionInfluenzaSARI

Identifiers

PMID31522968
PMCPMC7102713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.